FDA Should Raise Complete Response Issues Sooner, Companies Say

Drug Industry Daily
A A
Drugmakers are urging the FDA to raise drug review issues with sponsors earlier, as one company says its recent complete response letter came after a frustrating lack of communication from the agency.

To View This Article:

Login

Subscribe To Drug Industry Daily